Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly (vol 21, pg 302, 2018)

被引：1

作者：

Chiloiro, Sabrina ^{[1
]}

Mazziotti, Gherardo ^{[2
]}

Giampietro, Antonella ^{[1
]}

Bianchi, Antonio ^{[1
]}

Frara, Stefano ^{[3
]}

Mormando, Marilda ^{[1
]}

Pontecorvi, Alfredo ^{[1
]}

Giustina, Andrea ^{[3
]}

De Marinis, Laura ^{[1
]}

机构：

[1] Univ Cattolica Sacro Cuore, Pituitary Unit, Rome, Italy

[2] ASST Carlo Poma, Endocrine Unit, Mantua, Italy

[3] Univ Vita Salute San Raffaele, Milan, Italy

来源：

PITUITARY | 2018年 / 21卷 / 03期

关键词：

Acromegaly; Bone mineral density; IGF-I; Osteopathy; Pegvisomant; Somatostatin receptor ligands; Vertebral fractures;

D O I：

10.1007/s11102-018-0878-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The original version of the article contained an error in the results section of the Abstract. The vertebral fractures (VFs) odds ratio is incorrectly published as 61.0 and the correct value is 6.10.

引用

页码：309 / 309

页数：1